NVP-BEZ235对低氧大鼠肺血管管周肥大细胞的影响

柴晓宇; 韩倩; 吴艳萍; 王翔; 刘新民

doi:10.3969/j.issn.1006-0111.2017.05.005

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

x 关闭永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

NVP-BEZ235对低氧大鼠肺血管管周肥大细胞的影响

柴晓宇, 韩倩, 吴艳萍, 王翔, 刘新民

文章导航 > 药学实践与服务 > 2017 > 35(5): 407-410

柴晓宇, 韩倩, 吴艳萍, 王翔, 刘新民. NVP-BEZ235对低氧大鼠肺血管管周肥大细胞的影响[J]. 药学实践与服务, 2017, 35(5): 407-410. doi: 10.3969/j.issn.1006-0111.2017.05.005

引用本文:

CHAI Xiaoyu, HAN Qian, WU Yanping, WANG Xiang, LIU Xinmin. Effects of NVP-BEZ235 on pulmonary perivascular mast cells in hypoxia rats[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(5): 407-410. doi: 10.3969/j.issn.1006-0111.2017.05.005

Citation:

CHAI Xiaoyu, HAN Qian, WU Yanping, WANG Xiang, LIU Xinmin. Effects of NVP-BEZ235 on pulmonary perivascular mast cells in hypoxia rats[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(5): 407-410. doi: 10.3969/j.issn.1006-0111.2017.05.005

NVP-BEZ235对低氧大鼠肺血管管周肥大细胞的影响

doi: 10.3969/j.issn.1006-0111.2017.05.005

北京大学第一医院老年科, 北京 100034

基金项目: 国家自然科学基金（81270114）

Effects of NVP-BEZ235 on pulmonary perivascular mast cells in hypoxia rats

Department of Geriatrics, First Hospital of Peking University, Beijing 100034, China

摘要: 目的评价PI3K/mTOR双重抑制剂NVP-BEZ235对低压、低氧诱导的大鼠肺血管管周肥大细胞的分布以及脱颗粒状态的影响。方法低氧组SD雄性大鼠于低压低氧培养箱（50.5 kPa）内培养，治疗组隔天给予NVP-BEZ235（35 mg/kg）干预，对照组匹配饲养条件并在当地气压常氧环境饲养，21 d后全部动物以5%戊巴比妥钠麻醉后取材。肺组织固定后进行石蜡包埋并行苏木素伊红染色和甲苯胺蓝染色。结果低氧组大鼠肺血管管周肥大细胞数量较对照组增多，聚集明显。低氧组不同管径的肺血管（<50 μm，50~100 μm，>100 μm）管周的肥大细胞聚集情况及脱颗粒细胞比例较对照组增多，具有统计学差异（P<0.05），而NVP-BEZ235干预组较低氧组肺血管管周肥大细胞数量减少（P<0.05），且能降低管径50~100 μm的肺血管周围低氧组脱颗粒的肥大细胞比例（P=0.000 3）。结论 NVP-BEZ235可以抑制低压低氧诱导的大鼠肺血管管周肥大细胞的聚集及中等管径血管管周脱颗粒细胞比例。
- 磷脂酰肌醇-3-激酶 /
- 肥大细胞 /
- 低氧 /
- 肺血管
Abstract: Objective To assess the effects of PI3K/mTOR dual inhibitor NVP-BEZ235 on the distribution and degranulation of perivascularmast cells in the lung of hypobaric hypoxia rats. Methods SD male rats in the hypoxia group were raised in the specific hypoxic incubator (50.5 kPa).The intervene group received NVP-BEZ235 training (35 mg/kg) intervention once every two days.The control group was fed in the conditions comparable to the other groups at local pressure and normoxia environment. After 21 days, all rats were sacrificed with injection of 5% pentobarbital sodium. Lung tissues were fixed and embedded in paraffin for further hematoxylin-eosin staining and toluidine blue staining. Results Compared with the control group, the number of pulmonary perivascular mast cells in the hypoxia group increased significantly. Hypoxia group had more mast cell accumulation and larger degranulation ratio around different diameters of pulmonary vessels (less than 50 μm, 50-100 μm, larger than 100 μm) than the control group (P< 0.05).The mast cell numbers decreased in NVP-BEZ235 intervention group compared with hypoxia group (P<0.05).The degranulation ratio of pulmonary vascular mast cells around 50-100 μm in the intervention group was smaller than the hypoxia group (P=0.000 3). Conclusion NVP-BEZ235 inhibits the aggregation of pulmonary perivascular mast cells and degranulation ratio of median diameter pulmonary perivascular mast cells in hypobaric hypoxia rats.
- phosphatidylionsitol-3-kinases /
- mast cell /
- hypoxia /
- pulmonary vascular

[1]	Maxova H, Herget J, Vizek M. Lung mast cells and hypoxic pulmonary hypertension［J］. Physiol Res, 2012, 61 (1):1-11.
[2]	Humbert M, Montani D, Evgenov OV, et al. Definition and classification of pulmonary hypertension［J］. Handb Exp Pharmacol, 2013, 218:3-29.
[3]	Poor HD, Girgis R, Studer SM. World Health Organization Group Ⅲ pulmonary hypertension［J］. Prog Cardiovasc Dis, 2012, 55 (2):119-127.
[4]	Hoffmann J, Yin J, Kukucka M, et al. Mast cells promote lung vascular remodelling in pulmonary hypertension［J］. Eur Respir J, 2011, 37 (6):1400-1410.
[5]	Karar J, Cerniglia GJ, Lindsten T, et al. Dual PI3K/mTOR inhibitor NVP-BEZ235 suppresses hypoxia-inducible factor (HIF)-1 alpha expression by blocking protein translation and increases cell death under hypoxia［J］. Cancer Biol Ther, 2012, 13 (11):1102-1111.
[6]	Fang X, Li K, Tao X, et al. Effects of phosphoinositide 3-kinase on protease-induced acute and chronic lung inflammation, remodeling, and emphysema in rats［J］. Chest, 2013, 143 (4):1025-1035.
[7]	Blatt K, Herrmann H, Mirkina I, et al. The PI3-kinase/mTOR-targeting drug NVP-BEZ235 inhibits growth and IgE-dependent activation of human mast cells and basophils［J］. PLoS One, 2012, 7 (1):e29925.
[8]	Council NR. Guide for the care and use of laboratory animals［M］.8th Ed. Washington DC:National Academies Press,2011:11-151.
[9]	Tucker A, Mcmurtry IF, Alexander AF, et al. Lung mast cell density and distribution in chronically hypoxic animals［J］. J Appl Physiol Respir Environ Exerc Physiol, 1977, 42 (2):174-178.
[10]	Bartelds B, Van Loon RL, Mohaupt S, et al. Mast cell inhibition improves pulmonary vascular remodeling in pulmonary hypertension［J］. Chest, 2012, 141 (3):651-660.
[11]	Maira SM, Stauffer F, Brueggen J, et al. Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity［J］. Mol Cancer Ther, 2008, 7 (7):1851-1863.
[12]	Nathan SD, Hassoun PM. Pulmonary hypertension due to lung disease and/or hypoxia［J］. Clin Chest Med, 2013, 34 (4):695-705.
[13]	Jin H, Wang Y, Zhou L, et al. Melatonin attenuates hypoxic pulmonary hypertension by inhibiting the inflammation and the proliferation of pulmonary arterial smooth muscle cells［J］. J Pineal Res, 2014, 57 (4):442-450.
[14]	Stenmark KR, Fagan KA, Frid MG. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms［J］. Circ Res, 2006, 99 (7):675-691.

[1]	陈炳辰, 佟达丰, 万苗, 闫飞虎, 姚建忠. UPLC-MS/MS法测定小鼠血浆中紫杉醇脂肪酸酯前药及其药代动力学研究 . 药学实践与服务, 2024, 42(8): 341-345. doi: 10.12206/j.issn.2097-2024.202404082
[2]	李想, 陆鸿远, 张明玉, 高欢, 姚东, 许子华. 米格列醇激活UCP1介导棕色脂肪对冷暴露小鼠损伤的研究 . 药学实践与服务, 2024, 42(): 1-6. doi: 10.12206/j.issn.2097-2024.202404005
[3]	陈炳辰, 王思真, 郭贝贝, 杨峰. 紫杉醇棕榈酸酯的合成及其脂质体的制备与处方研究 . 药学实践与服务, 2024, 42(9): 379-384, 410. doi: 10.12206/j.issn.2097-2024.202404062
[4]	桂明珠, 李静, 李志玲. 儿童伏立康唑的血药浓度与CYP2C19、CYP2C9和CYP3A5基因多态性的相关性研究 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202402020
[5]	刘丽艳, 余小翠, 孙传铎. 纳武利尤单抗治疗非小细胞肺癌有效性及安全性的Meta分析 . 药学实践与服务, 2024, 42(10): 451-456. doi: 10.12206/j.issn.2097-2024.202310044
[6]	宋雨桐, 夏德润, 顾珩, 唐少文, 易洪刚, 沃红梅. 帕博利珠单抗与铂类化疗方案在晚期非小细胞肺癌一线治疗中的药物经济学评价 . 药学实践与服务, 2024, 42(8): 334-340. doi: 10.12206/j.issn.2097-2024.202303023
[7]	冯志惠, 邓仪卿, 叶冰, 安培, 张宏, 张海军. 雀梅藤石油醚提取物诱导三阴性乳腺癌细胞凋亡的实验研究 . 药学实践与服务, 2024, 42(6): 253-259. doi: 10.12206/j.issn.2097-2024.202311055
[8]	修建平, 杨朝爱, 刘禧澳, 潘乾禹, 韦广旭, 王卫星. 全反式维甲酸对肝星状细胞活化及氧化应激的作用和机制探索 . 药学实践与服务, 2024, 42(7): 291-296. doi: 10.12206/j.issn.2097-2024.202312054
[9]	姜涛, 徐卫凡, 蒋益萍, 夏天爽, 辛海量. 巴戟天丸组方对Aβ损伤成骨细胞的作用及基于网络药理学的机制研究 . 药学实践与服务, 2024, 42(7): 285-290, 296. doi: 10.12206/j.issn.2097-2024.202305011
[10]	杨媛媛, 安晓强, 许佳捷, 江键, 梁媛媛. 正极性驻极体联合5-氟尿嘧啶对瘢痕成纤维细胞生长抑制的协同作用 . 药学实践与服务, 2024, 42(6): 244-247. doi: 10.12206/j.issn.2097-2024.202310027
[11]	迟文雅, 袁艳, 李伟林, 吴茼妤, 俞媛. 负载骨髓间充质干细胞/白藜芦醇脂质体的水凝胶支架用于创伤性脑损伤治疗 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202406034
[12]	张广雨, 杜晶, 刘梦珍, 朱丹妮, 闫慧, 刘冲. 新斯的明与山莨菪碱联合应用对肺型氧中毒的保护作用及其机制的研究 . 药学实践与服务, 2024, 42(10): 433-438, 444. doi: 10.12206/j.issn.2097-2024.202310049
[13]	崔亚玲, 吴琼, 马良煜, 胡北, 姚东, 许子华. 肝素钠肌醇烟酸酯乳膏中肌醇烟酸酯皮肤药动学研究 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202404006

点击查看大图

计量

文章访问数: 2772
HTML全文浏览量: 259
PDF下载量: 718
被引次数: 0

NVP-BEZ235对低氧大鼠肺血管管周肥大细胞的影响

doi: 10.3969/j.issn.1006-0111.2017.05.005

北京大学第一医院老年科, 北京 100034

基金项目: 国家自然科学基金（81270114）

收稿日期: 2016-11-01
修回日期: 2017-03-21

关键词:

磷脂酰肌醇-3-激酶 /

肥大细胞 /

低氧 /

肺血管

摘要: 目的评价PI3K/mTOR双重抑制剂NVP-BEZ235对低压、低氧诱导的大鼠肺血管管周肥大细胞的分布以及脱颗粒状态的影响。方法低氧组SD雄性大鼠于低压低氧培养箱（50.5 kPa）内培养，治疗组隔天给予NVP-BEZ235（35 mg/kg）干预，对照组匹配饲养条件并在当地气压常氧环境饲养，21 d后全部动物以5%戊巴比妥钠麻醉后取材。肺组织固定后进行石蜡包埋并行苏木素伊红染色和甲苯胺蓝染色。结果低氧组大鼠肺血管管周肥大细胞数量较对照组增多，聚集明显。低氧组不同管径的肺血管（<50 μm，50~100 μm，>100 μm）管周的肥大细胞聚集情况及脱颗粒细胞比例较对照组增多，具有统计学差异（P<0.05），而NVP-BEZ235干预组较低氧组肺血管管周肥大细胞数量减少（P<0.05），且能降低管径50~100 μm的肺血管周围低氧组脱颗粒的肥大细胞比例（P=0.000 3）。结论 NVP-BEZ235可以抑制低压低氧诱导的大鼠肺血管管周肥大细胞的聚集及中等管径血管管周脱颗粒细胞比例。

English Abstract

Effects of NVP-BEZ235 on pulmonary perivascular mast cells in hypoxia rats

Department of Geriatrics, First Hospital of Peking University, Beijing 100034, China

Received Date: 2016-11-01
Rev Recd Date: 2017-03-21

Keywords:

Abstract: Objective To assess the effects of PI3K/mTOR dual inhibitor NVP-BEZ235 on the distribution and degranulation of perivascularmast cells in the lung of hypobaric hypoxia rats. Methods SD male rats in the hypoxia group were raised in the specific hypoxic incubator (50.5 kPa).The intervene group received NVP-BEZ235 training (35 mg/kg) intervention once every two days.The control group was fed in the conditions comparable to the other groups at local pressure and normoxia environment. After 21 days, all rats were sacrificed with injection of 5% pentobarbital sodium. Lung tissues were fixed and embedded in paraffin for further hematoxylin-eosin staining and toluidine blue staining. Results Compared with the control group, the number of pulmonary perivascular mast cells in the hypoxia group increased significantly. Hypoxia group had more mast cell accumulation and larger degranulation ratio around different diameters of pulmonary vessels (less than 50 μm, 50-100 μm, larger than 100 μm) than the control group (P< 0.05).The mast cell numbers decreased in NVP-BEZ235 intervention group compared with hypoxia group (P<0.05).The degranulation ratio of pulmonary vascular mast cells around 50-100 μm in the intervention group was smaller than the hypoxia group (P=0.000 3). Conclusion NVP-BEZ235 inhibits the aggregation of pulmonary perivascular mast cells and degranulation ratio of median diameter pulmonary perivascular mast cells in hypobaric hypoxia rats.